The global nebulizer market size to cross USD 900 million by 2020, growing at a CAGR of 7% during the forecast period. The global nebulizer market is one of the steady growing segments in the global medical devices market. It is expected to grow at a healthy pace during the forecast period. This surge can be attributable to the growing prevalence of asthma, chronic obstructive pulmonary disease (COPD) patients, cystic fibrosis, and the outbreak of the COVID-19 pandemic. The rising incidence of chronic respiratory diseases is increasing the demand for nebulizers at a significant rate over the past few years across the globe. According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.
The rise in COVID-19 cases across the globe has increased the demand for nebulizers. The device’s usage to treat the coronavirus affected patients is growing during the COVID-19 pandemic. According to the WHO, more than 180 countries are affected by COVID-19. Italy, Spain, the UK, the US, China, France, Spain, Iran, Germany, the Netherlands, and Belgium accounted for more than 75% of the cases. With 20% to 40% and 5% to 15% of COVID-19 patients requiring hospitalization and intensive/emergency care, the demand for medical ventilators and nebulizers to deliver medication directly to the lungs is likely to grow phenomenally between 2020 and 2021.
- The mesh segment is expected to grow at the CAGR of over 9% during the period 2029–2025. The growth of the segment can be attributed to consistent and improved aerosol generation efficiency.
- The portable segment is expected to witness an incremental growth of over $259 million by 2025 on account of the increased inclination toward hand-held and home nebulization therapies.
- The home healthcare segment is likely to observe a revenue of over $425 million by 2025 due to the growing shift from hospitals to home care settings and the increasing elder population.
- The nebulizer market in India is expected to grow at the CAGR of over 10% during the period 2019–2025. The demand for these devices is growing because of the increased awareness of inhaling technology and the high prevalence of several respiratory disorders.
- The demand for the latest smart, mesh and portable devices is likely to drive the US nebulizer market, expecting to register an incremental growth of over $ 120 million by 2025.
GLOBAL NEBULIZER MARKET SEGMENTATION
This research report includes a detailed segmentation by
INSIGHTS BY PRODUCT
Jet nebulizers are widely drug delivery machines across the globe. The segment accounts for the largest market revenue. However, it is likely to decline on account of the growing popularity and adoption of mesh devices. An important driver, which is influencing their usage, is the effectiveness in delivering formulations that cannot be delivered with pressurized metered-dose and dry powder inhalers. However, these devices are incorporated with ventilators to synchronize aerosol delivery with inspiration, maintain constant tidal volume, and avoid drug waste. This factor has increased the usage of jet type in ICUs to treat critically ill patients.
The mesh segment accounted for over 26% of market shares. The segment is likely to grow due to enhancements in inhalation technology, which has led to the development of mesh devices using micropump technology for aerosol production. Vibrating mesh nebulizers are the latest technologically advanced devices that overcome the disadvantages of both jet and ultrasonic inhaling machines. The small, quiet, and portable, designed to improve the convenience and appeal to the user, especially those living an active lifestyle.
INSIGHTS BY PORTABILITY
The tabletop devices segment is likely to retain its dominance; however, portable nebulizers are expected to grow at the highest CAGR during the forecast period. The usage of tabletop devices in emergency care and home healthcare settings is increasing their application world over. The resistance to change to the latest inhaling technology in the elderly population is helping to consolidate the segment. The tabletop segment is likely to witness an absolute growth of over 36% and an incremental growth of around $173.6 million during the forecast period.
The portable devices segment is expected to incremental growth of over $259 million by 2025. Portable devices are widely adopted among asthma patients and infants and children. They can efficiently deliver bronchodilators and corticosteroids in patients as the drugs are delivered directly into the lungs. Portable devices are ideal for infants and children because they are lightweight and can be carried around, unlike tabletop devices. The growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants.
INSIGHTS BY END-USER
In 2019, the hospital segment accounted for a share of 54% in the global nebulizer market. The increase in the number of hospitals offering treatment to several patient groups requiring nebulizers. For decades, hospitals have been the first point of contact for emergencies from asthma, COPD, and other respiratory disorders. The rising geriatric population is fueling the hospital segment.
Home healthcare settings are witnessing a high demand for nebulizers. The COVID-19 pandemic situation has changed the patient pathway for the treatment of diseases. Several COPD and asthma patients are diverted to home healthcare settings. To prevent the spread of the virus, the majority of the respiratory patients are diverted to home healthcare devices in developed countries. These factors are driving the demand for nebulizers across home healthcare settings.
INSIGHTS BY GEOGRAPHY
The North American market is growing at a moderate rate. Although the region is expected to grow at a slower rate than other regions, the COVID-19 pandemic has fueled a surge in nebulizers in the region, especially in the US. The country will witness a positive growth as national health spending is projected to grow at an average annual rate of 5.4% for 2019–2028, reaching $6.2 trillion by 2028. North America experienced a large-scale adoption of nebulizers over the past decade. The rise in pollution rates, along with the growing number of cases related to respiratory troubles, even for neo-natal care, is one of the major reasons that has boosted the overall demand in North America. However, the COVID-19 pandemic situation has affected North America drastically. The number of people affected by COVID-19 is on the higher side; more than lakh people are affected by the coronavirus. A large number of people are admitted to emergency rooms and are on ventilators.
INSIGHTS BY VENDORS
The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices. OMRON, Koninklijke Philips, Drive DeVilbiss International, PARI, Feellife Health, Besco Medical, and Rossmax International, and Ca-Mi are the key market players dominating the market. Although the large vendors dominate, they are witnessing heavy competition from regional and local companies from India, China, Italy, and Germany. Many regional vendors also are offering cost-effective nebulizers in Europe, APAC, and the Middle East & Africa regions.
The nebulizer market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Products
- Home Healthcare
- North America
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia